Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation-Reference-Cited by-同舟云学术

Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation

Published:2017-04-11 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Skeoch S.^ORCID,Cristinacce P. L. Hubbard,Williams H.,Pemberton P.,Xu D.,Sun J.,James J.,Yuan C.,Hatsukami T.,Hockings P. D.,Alexander M. Y.,Waterton J. C.^ORCID,Bruce I. N.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-00989-w.pdf

Reference47 articles.

1. Alamanos, Y., Voulgari, P. V. & Drosos, A. A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36, 182–188, doi: 10.1016/j.semarthrit.2006.08.006 (2006).

2. Gabriel, S. E. et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 48, 54–58, doi: 10.1002/art.10705 (2003).

3. Peters, M. J. et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum. 61(11), 1571–9, doi: 10.1002/art.v61:11 (2009).

4. Goodson, N. et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann. Rheum. Dis. 64, 1595–1601, doi: 10.1136/ard.2004.034777 (2005).

5. Maradit-Kremers, H. H. et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 52(2), 402–11, doi: 10.1002/(ISSN)1529-0131 (2005).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UltraAIGenomics: Artificial Intelligence-Based Cardiovascular Disease Risk Assessment by Fusion of Ultrasound-Based Radiomics and Genomics Features for Preventive, Personalized and Precision Medicine: A Narrative Review;Reviews in Cardiovascular Medicine;2024-05-22

2. A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool;Frontiers in Bioscience-Landmark;2023-10-19

3. Imaging in inflammatory arthritis: progress towards precision medicine;Nature Reviews Rheumatology;2023-09-08

4. Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future;Frontiers in Medicine;2022-06-30

5. Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review;Diagnostics;2022-05-14